We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Colgate-Palmolive has been growing revenues and managing the challenging economic environment well with strong earnings growth. The company offers stability and reliability in a volatile market ...
Colgate Palmolive ended at record closing high after breaking the recent consolidation range and formed long bullish candlestick pattern on the daily charts with healthy volumes. Prabhudas ...
Colgate-Palmolive in Focus Colgate-Palmolive (CL) is headquartered in New York, and is in the Consumer Staples sector. The stock has seen a price change of 10.97% since the start of the year.
Looking at the universe of stocks we cover at Dividend Channel, on 4/19/24, Colgate-Palmolive Co. (Symbol: CL), CVS Health Corporation (Symbol: CVS), and Medical Properties Trust Inc (Symbol: MPW ...
For the last reported quarter, it was expected that Colgate-Palmolive would post earnings of $0.85 per share when it actually produced earnings of $0.87, delivering a surprise of +2.35%.
RBC Capital analyst Nik Modi maintained a Hold rating on Colgate-Palmolive (CL – Research Report) on April 17 and set a price target of $88.00. The company’s shares closed yesterday at $86.71.
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from ...
Colgate-Palmolive's estimated fair value is US$124 based on 2 Stage Free Cash Flow to Equity Current share price of US$87.13 suggests Colgate-Palmolive is potentially 30% undervalued Analyst price ...